Literature DB >> 11973417

Inhibitory effect of activated protein C on cerebral vasospasm after subarachnoid hemorrhage in the rabbit.

Yusuke Mizuno1, Hiroshi Azuma, Yoshifumi Ito, Eiji Isotani, Kikuo Ohno, Kimiyoshi Hirakawa.   

Abstract

This study investigated whether activated protein C (APC) improves the cerebral vasospasm in an experimental subarachnoid hemorrhage that was produced by the intracisternal injection of autologous blood. Male rabbits were divided into the following four groups: APC 0.1-and 0.5-mg groups, in which 0.1 and 0.5 mg APC were injected into the cisterna magna, respectively; a placebo group, in which saline was injected instead of APC; and a sham operation group that did not get injections of autologous blood, APC, and saline. On day 2, amount of clot in the basal cistern was significantly (p < 0.01) decreased in the APC 0.5-mg group. Percent diameter of the basilar artery on day 2 to that before injecting the blood was angiographically determined as 97.1 +/- 3.8% in the APC 0.5-mg group, which was significantly (p < 0.001) greater than the corresponding value in the placebo group (74.8 +/- 3.4%). The impaired endothelium-dependent relaxation following subarachnoid hemorrhage was normalized in the APC 0.5-mg group (p < 0.0001). These results suggest that APC would improve cerebral vasospasm following subarachnoid hemorrhage, possibly by decreasing the amount of subarachnoid clot and normalizing the impaired nitric oxide production/release.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11973417     DOI: 10.1097/00005344-200205000-00014

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol        ISSN: 0160-2446            Impact factor:   3.105


  1 in total

1.  Hypercholesterolemia increases vasospasm resulting from basilar artery subarachnoid hemorrhage in rabbits which is attenuated by Vitamin E.

Authors:  Mehdi Sasani; Burak Yazgan; Irfan Celebi; Nurgul Aytan; Betul Catalgol; Tunc Oktenoglu; Tuncay Kaner; Nesrin Kartal Ozer; Ali Fahir Ozer
Journal:  Surg Neurol Int       Date:  2011-03-14
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.